GB201701572D0 - Methods, arrays and uses thereof - Google Patents

Methods, arrays and uses thereof

Info

Publication number
GB201701572D0
GB201701572D0 GBGB1701572.8A GB201701572A GB201701572D0 GB 201701572 D0 GB201701572 D0 GB 201701572D0 GB 201701572 A GB201701572 A GB 201701572A GB 201701572 D0 GB201701572 D0 GB 201701572D0
Authority
GB
United Kingdom
Prior art keywords
arrays
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1701572.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovia AB
Original Assignee
Immunovia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia AB filed Critical Immunovia AB
Priority to GBGB1701572.8A priority Critical patent/GB201701572D0/en
Publication of GB201701572D0 publication Critical patent/GB201701572D0/en
Priority to BR112019015633-0A priority patent/BR112019015633A2/pt
Priority to PCT/EP2018/052423 priority patent/WO2018141804A1/en
Priority to US16/479,064 priority patent/US20190382849A1/en
Priority to AU2018214180A priority patent/AU2018214180A1/en
Priority to EP18703545.6A priority patent/EP3577464A1/en
Priority to MX2019008911A priority patent/MX2019008911A/es
Priority to RU2019123695A priority patent/RU2019123695A/ru
Priority to KR1020197022175A priority patent/KR20190109422A/ko
Priority to JP2019541330A priority patent/JP2020507760A/ja
Priority to CA3051968A priority patent/CA3051968A1/en
Priority to CN201880009309.3A priority patent/CN110325860A/zh
Priority to IL268244A priority patent/IL268244A/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB1701572.8A 2017-01-31 2017-01-31 Methods, arrays and uses thereof Ceased GB201701572D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1701572.8A GB201701572D0 (en) 2017-01-31 2017-01-31 Methods, arrays and uses thereof
CN201880009309.3A CN110325860A (zh) 2017-01-31 2018-01-31 方法、阵列和其用途
MX2019008911A MX2019008911A (es) 2017-01-31 2018-01-31 Metodos, matrices y usos de estos.
PCT/EP2018/052423 WO2018141804A1 (en) 2017-01-31 2018-01-31 Methods, arrays and uses thereof
US16/479,064 US20190382849A1 (en) 2017-01-31 2018-01-31 Methods, arrays and uses thereof
AU2018214180A AU2018214180A1 (en) 2017-01-31 2018-01-31 Methods, arrays and uses thereof
EP18703545.6A EP3577464A1 (en) 2017-01-31 2018-01-31 Methods, arrays and uses thereof
BR112019015633-0A BR112019015633A2 (pt) 2017-01-31 2018-01-31 Métodos, matrizes e utilizações dos mesmos
RU2019123695A RU2019123695A (ru) 2017-01-31 2018-01-31 Способы, массивы и их применение
KR1020197022175A KR20190109422A (ko) 2017-01-31 2018-01-31 방법, 어레이 및 그 용도
JP2019541330A JP2020507760A (ja) 2017-01-31 2018-01-31 方法、アレイ、およびそれらの使用
CA3051968A CA3051968A1 (en) 2017-01-31 2018-01-31 Methods, arrays and uses thereof
IL268244A IL268244A (en) 2017-01-31 2019-07-24 Methods, arrays and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1701572.8A GB201701572D0 (en) 2017-01-31 2017-01-31 Methods, arrays and uses thereof

Publications (1)

Publication Number Publication Date
GB201701572D0 true GB201701572D0 (en) 2017-03-15

Family

ID=58462729

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1701572.8A Ceased GB201701572D0 (en) 2017-01-31 2017-01-31 Methods, arrays and uses thereof

Country Status (13)

Country Link
US (1) US20190382849A1 (enExample)
EP (1) EP3577464A1 (enExample)
JP (1) JP2020507760A (enExample)
KR (1) KR20190109422A (enExample)
CN (1) CN110325860A (enExample)
AU (1) AU2018214180A1 (enExample)
BR (1) BR112019015633A2 (enExample)
CA (1) CA3051968A1 (enExample)
GB (1) GB201701572D0 (enExample)
IL (1) IL268244A (enExample)
MX (1) MX2019008911A (enExample)
RU (1) RU2019123695A (enExample)
WO (1) WO2018141804A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
CA3142634A1 (en) * 2019-07-03 2021-01-07 Crystal Bioscience Inc. Anti-b7-h3 antibody and methods of use thereof
KR102289278B1 (ko) * 2019-07-09 2021-08-13 주식회사 베르티스 췌장암 진단용 바이오마커 패널 및 그 용도
JP2023507369A (ja) * 2019-12-20 2023-02-22 メディミューン，エルエルシー グリピカン３を標的とするキメラ抗原受容体を用いて癌を治療する組成物及び方法
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
AU2022244125A1 (en) * 2021-03-26 2023-10-19 BioNTech SE Combination therapy with an anti-ca19-9 antibody and folfirinox in the treatment of cancer
CN113336851B (zh) * 2021-06-30 2021-12-24 徐州医科大学 新型全人源抗人b7h3抗体、包含所述抗体的组合物及其应用
CN120177800B (zh) * 2025-05-23 2025-10-10 四川大学 血液生物标志物cfp在制备急性胰腺炎诊断试剂的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US8632983B2 (en) * 2005-04-15 2014-01-21 Van Andel Research Institute Biomarkers for pancreatic cancer and diagnostic methods
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
WO2012031374A1 (zh) * 2010-09-09 2012-03-15 北京同为时代生物技术有限公司 用于诊断上皮源性癌症的血液标志物及其单克隆抗体
GB201103726D0 (en) 2011-03-04 2011-04-20 Immunovia Ab Method, array and use thereof
GB201206323D0 (en) * 2012-04-10 2012-05-23 Immunovia Ab Methods and arrays for use in the same
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
GB201516801D0 (en) * 2015-09-22 2015-11-04 Immunovia Ab Method, array and use thereof

Also Published As

Publication number Publication date
US20190382849A1 (en) 2019-12-19
BR112019015633A2 (pt) 2020-03-17
JP2020507760A (ja) 2020-03-12
KR20190109422A (ko) 2019-09-25
AU2018214180A1 (en) 2019-08-08
CA3051968A1 (en) 2018-08-09
IL268244A (en) 2019-09-26
EP3577464A1 (en) 2019-12-11
CN110325860A (zh) 2019-10-11
RU2019123695A (ru) 2021-03-02
MX2019008911A (es) 2019-09-26
WO2018141804A1 (en) 2018-08-09

Similar Documents

Publication Publication Date Title
IL320713A (en) Antibodies, uses and methods
IL315612A (en) Self-healing systems, methods, and related components
PL3347379T3 (pl) Przeciwciała anty-tigit, przeciwciała anty-pvrig i ich połączenia
GB201916874D0 (en) .
IL262824A (en) Method, array and their uses
GB201512203D0 (en) Agents,uses and methods
IL246597A0 (en) Systems Spectrometric Methods and Applications
IL268244A (en) Methods, arrays and uses thereof
PT3397702T (pt) Tinta piezorresistiva, métodos e utilizações da mesma
GB201516801D0 (en) Method, array and use thereof
PT3688359T (pt) Dispositivo de ligação, disposição e método
IL252430A0 (en) Antibodies, uses and methods
GB201512215D0 (en) Agents,uses and methods
ZA201806640B (en) Gitr antibodies, methods, and uses
SG11202001206YA (en) Emulsions, methods and uses thereof
PL3319697T3 (pl) System fitness, układ zestawu fitness i funkcjonalne elementy fitness
PT3545144T (pt) Elementos de nó, kits e métodos
PL3359676T3 (pl) Układ transpozonowy, zestaw zawierający ten układ oraz zastosowania tego układu
IL249122A0 (en) History of imidazole- or 4,2,1-triazole and their use
PL3386988T3 (pl) Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie
IL275211A (en) Fast and flexible segment chains - division
HUE047919T2 (hu) Biológiai asszimilációra alkalmas proteo-melanisztikus komplex, készítmény és felhasználásai
EP3218934A4 (en) Large scale, low cost nanosensor, nano-needle, and nanopump arrays
SG11202001154QA (en) Cyanobacterial extracts, processes for preparing the same and uses thereof
GB201904472D0 (en) Methods, arrays and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)